Payment overview · 2025
General Payments
$117.31
6 reported records · 6 companies
Healthcare provider profile · identity verified
Danielle R Westrick, MD
Allopathic & Osteopathic Physicians|Family Medicine · GLANDORF, OH · NPI 1629311311
Verified facts
What the public records show
CMS Open Payments records show Danielle R Westrick, MD received $117.31 in general payments during 2025 across 6 reported records.
Exact Sciences Corporation accounted for 20.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 51 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Symbicort by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 157 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $23.45 | 20.0% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $22.27 | 19.0% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $19.07 | 16.3% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $18.86 | 16.1% | 1 | 2025 |
| Madrigal Pharmaceuticals | Unresolved — no canonical attribution shown | $17.66 | 15.1% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $16.00 | 13.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $117.31 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $23.45 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $22.27 | 1 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $19.07 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $18.86 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $18.86 | 1 | 2025 |
Source payment records
|
|||||
| REZDIFFRA Normalized: rezdiffra |
Drug | Madrigal Pharmaceuticals | $17.66 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $16.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 28 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
51 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
157 | 20 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
28 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
28 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 824 | 169 |
| Levothyroxine Sodium | Levothyroxine Sodium | 563 | 116 |
| Omeprazole | Omeprazole | 447 | 99 |
| Amlodipine Besylate | Amlodipine Besylate | 409 | 98 |
| Pantoprazole Sodium | Pantoprazole Sodium | 392 | 70 |
| Lisinopril | Lisinopril | 386 | 90 |
| Metoprolol Succinate | Metoprolol Succinate | 353 | 86 |
| Sertraline Hcl | Sertraline Hcl | 352 | 69 |
| Metoprolol Tartrate | Metoprolol Tartrate | 348 | 59 |
| Eliquis | Apixaban | 306 | 41 |
| Losartan Potassium | Losartan Potassium | 299 | 63 |
| Trazodone Hcl | Trazodone Hcl | 290 | 58 |
| Gabapentin | Gabapentin | 275 | 54 |
| Potassium Chloride | Potassium Chloride | 269 | 52 |
| Furosemide | Furosemide | 247 | 58 |
| Metformin Hcl | Metformin Hcl | 226 | 45 |
| Hydrochlorothiazide | Hydrochlorothiazide | 221 | 61 |
| Tradjenta | Linagliptin | 221 | 14 |
| Buspirone Hcl | Buspirone Hcl | 216 | 41 |
| Donepezil Hcl | Donepezil Hcl | 198 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 168 | 38 |
| Jardiance | Empagliflozin | 157 | 20 |
| Bumetanide | Bumetanide | 151 | 34 |
| Pravastatin Sodium | Pravastatin Sodium | 148 | 29 |
| Meloxicam | Meloxicam | 145 | 45 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 141 | 21 |
| Famotidine | Famotidine | 140 | 30 |
| Prednisone | Prednisone | 138 | 81 |
| Tamsulosin Hcl | Tamsulosin Hcl | 138 | 31 |
| Simvastatin | Simvastatin | 133 | 37 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 131 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 127 | 26 |
| Januvia | Sitagliptin Phosphate | 127 | 15 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 127 | 22 |
| Fluoxetine Hcl | Fluoxetine Hcl | 124 | 32 |
| Carvedilol | Carvedilol | 120 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 116 | 46 |
| Levetiracetam | Levetiracetam | 109 | 13 |
| Xarelto | Rivaroxaban | 109 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 107 | 28 |
| Ropinirole Hcl | Ropinirole Hcl | 105 | 21 |
| Mirtazapine | Mirtazapine | 104 | 21 |
| Azithromycin | Azithromycin | 102 | 83 |
| Warfarin Sodium | Warfarin Sodium | 101 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 100 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 97 | 16 |
| Memantine Hcl | Memantine Hcl | 96 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 96 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 94 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 90 | 24 |
| Allopurinol | Allopurinol | 89 | 24 |
| Cephalexin | Cephalexin | 87 | 65 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 86 | 16 |
| Ozempic | Semaglutide | 85 | 21 |
| Spironolactone | Spironolactone | 85 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 84 | 35 |
| Lorazepam | Lorazepam | 84 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 83 | 15 |
| Baclofen | Baclofen | 80 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 80 | 21 |
| Tramadol Hcl | Tramadol Hcl | 80 | 26 |
| Alprazolam | Alprazolam | 77 | 20 |
| Bupropion Xl | Bupropion Hcl | 76 | 25 |
| Amiodarone Hcl | Amiodarone Hcl | 74 | suppressed |
| Cefdinir | Cefdinir | 73 | 55 |
| Alendronate Sodium | Alendronate Sodium | 72 | 14 |
| Glimepiride | Glimepiride | 69 | 18 |
| Montelukast Sodium | Montelukast Sodium | 68 | 12 |
| Divalproex Sodium | Divalproex Sodium | 66 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 65 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 64 | 20 |
| Pioglitazone Hcl | Pioglitazone Hcl | 60 | 16 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 58 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 57 | 20 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 56 | 29 |
| Glipizide Er | Glipizide | 54 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 53 | 42 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 52 | 14 |
| Brilinta | Ticagrelor | 51 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 51 | suppressed |
| Lamotrigine | Lamotrigine | 50 | suppressed |
| Lovastatin | Lovastatin | 49 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 49 | 18 |
| Enalapril Maleate | Enalapril Maleate | 48 | 11 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 47 | suppressed |
| Glipizide | Glipizide | 46 | 12 |
| Fenofibrate | Fenofibrate | 45 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 44 | 29 |
| Fluconazole | Fluconazole | 44 | 27 |
| Methylprednisolone | Methylprednisolone | 44 | 37 |
| Topiramate | Topiramate | 43 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 41 | 41 |
| Nystatin | Nystatin | 40 | 15 |
| Finasteride | Finasteride | 39 | suppressed |
| Olanzapine | Olanzapine | 39 | suppressed |
| Digoxin | Digoxin | 38 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 38 | 29 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 38 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 37 | 16 |
| Ondansetron Odt | Ondansetron | 37 | 24 |
| Atenolol | Atenolol | 35 | suppressed |
| Pregabalin | Pregabalin | 35 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Aripiprazole | Aripiprazole | 33 | suppressed |
| Naproxen | Naproxen | 33 | suppressed |
| Sucralfate | Sucralfate | 33 | suppressed |
| Synthroid | Levothyroxine Sodium | 33 | suppressed |
| Nitroglycerin | Nitroglycerin | 32 | 19 |
| Novolog Flexpen | Insulin Aspart | 32 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 31 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 31 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 30 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 30 | suppressed |
| Ezetimibe | Ezetimibe | 29 | suppressed |
| Loperamide | Loperamide Hcl | 29 | 24 |
| Lacosamide | Lacosamide | 28 | suppressed |
| Mounjaro | Tirzepatide | 28 | suppressed |
| Rytary | Carbidopa/Levodopa | 28 | suppressed |
| Trulicity | Dulaglutide | 28 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 16 |
| Gemtesa | Vibegron | 27 | suppressed |
| Rexulti | Brexpiprazole | 27 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 27 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 26 | suppressed |
| Levetiracetam Er | Levetiracetam | 26 | suppressed |
| Myrbetriq | Mirabegron | 26 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 26 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Lactulose | Lactulose | 25 | suppressed |
| Estradiol | Estradiol | 24 | suppressed |
| Ibuprofen | Ibuprofen | 23 | 11 |
| Trospium Chloride | Trospium Chloride | 23 | suppressed |
| Amoxicillin | Amoxicillin | 22 | 17 |
| Carbamazepine Er | Carbamazepine | 22 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 18 |
| Aptiom | Eslicarbazepine Acetate | 21 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 20 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 20 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 20 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 20 | suppressed |
| Amantadine | Amantadine Hcl | 19 | suppressed |
| Clonazepam | Clonazepam | 19 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Nifedipine Er | Nifedipine | 18 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 17 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Acetic Acid | Acetic Acid | 16 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 16 | 11 |
| Fenofibrate | Fenofibrate,micronized | 16 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 16 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 16 | suppressed |
| Klor-Con M20 | Potassium Chloride | 16 | suppressed |
| Latanoprost | Latanoprost | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 15 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Anastrozole | Anastrozole | 14 | suppressed |
| Avonex Pen (4 Pack) | Interferon Beta-1a | 14 | suppressed |
| Celecoxib | Celecoxib | 14 | suppressed |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Rivastigmine | Rivastigmine | 14 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Admelog Solostar | Insulin Lispro | 12 | suppressed |
| Cilostazol | Cilostazol | 12 | suppressed |
| Desipramine Hcl | Desipramine Hcl | 12 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Verapamil Sr | Verapamil Hcl | 12 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Mesalamine | Mesalamine | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $117.31 · 6 records | Exact Sciences Corporation | BREZTRI, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, MOUNJARO, REZDIFFRA, The Cologuard Plus Collection Kit, ZEPBOUND | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error